Detalhe da pesquisa
1.
Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model.
Dis Esophagus
; 35(5)2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718471
2.
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma.
Proc Natl Acad Sci U S A
; 116(6): 2237-2242, 2019 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670657
3.
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
Ann Surg
; 274(6): 1009-1016, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31592898
4.
Predictive value of endoscopic esophageal findings for residual esophageal cancer after neoadjuvant chemoradiotherapy.
Endoscopy
; 53(11): 1098-1104, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33652496
5.
Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancer.
Endoscopy
; 52(3): 186-192, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31816658
6.
Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma.
Int J Cancer
; 145(10): 2792-2803, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018252
7.
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.
Gastroenterology
; 155(3): 784-798, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29885883
8.
Endoscopic ultrasound measurements for detection of residual disease after neoadjuvant chemoradiotherapy for esophageal cancer.
Endoscopy
; 51(4): 326-332, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30497088
9.
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Lancet Oncol
; 19(7): 965-974, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29861116
10.
Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Gastroenterology
; 153(1): 63-76.e14, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28286209
11.
Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.
Gastroenterology
; 152(5): 993-1001.e1, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28012849
12.
Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report.
BMC Cancer
; 18(1): 889, 2018 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30208867
13.
Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.
Gut
; 65(10): 1602-10, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26104750
14.
Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes.
Gastroenterology
; 149(6): 1511-1518.e5, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26248086
15.
Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: a prospective follow-up study.
Genes Chromosomes Cancer
; 54(2): 82-90, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25284618
16.
Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.
Gut
; 64(5): 700-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25034523
17.
Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.
Mol Med
; 21: 346-54, 2015 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25910066
18.
Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract.
J Transl Med
; 13: 115, 2015 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25884700
19.
Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence.
Scand J Gastroenterol
; 50(3): 321-32, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25562781
20.
Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers.
Gastrointest Endosc
; 80(6): 984-91, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085335